Genetic variants of IgG1 antibodies and Fc?RIIIa receptors influence the magnitude of antibody-dependent cell-mediated cytotoxicity against prostate cancer cells.
Genetic variants of IgG1 antibodies and Fc?RIIIa receptors influence the magnitude of antibody-dependent cell-mediated cytotoxicity against prostate cancer cells. Oncoimmunology. 2014 Jan 01; 3(1):e27317.